National Conference leader Farooq Abdullah joined a group of devotees in singing a bhajan during his visit to Vaishno Devi shrine Jammu & Kashmir's Katra. The 87-year-old was attending a ...

(ANI) The event was being held at the base camp for the pilgrimage to the Mata Vaishno Devi where he was seen singing the bhajan ‘Tune Mujhe Bulaya Sherawaliye’. The 87-year-old leader was ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

(Representative) “The special Poojan and Havan were performed to seek the blessings of Lord Ganesha and Mata Vaishno Devi for peace, welfare and prosperity of humanity and seek forgiveness for ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Plan your trip to the temple with these convenient trains. Tap to find the best train for your journey and book your tickets today.

Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial testing its experimental oral treatment usnoflast in people with amyotrophic lateral ...

Zydus Lifesciences made headlines on Wednesday as the US health regulator bestowed Orphan Drug Designation upon Usnoflast, their developing treatment for amyotrophic lateral sclerosis (ALS). The US ...